| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c17612db7d98bb4baf5d622f5250492 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-044 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2000-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ee13d772fe563964128609fdd06961d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be03319011b72ba10b0f4930ad25a7b9 |
| publicationDate |
2002-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2816633-A1 |
| titleOfInvention |
SCREENING METHOD FOR AGENTS LIKELY TO TREAT OBESITY |
| abstract |
The subject of the present invention is a method of screening for agents capable of treating obesity or one of the disorders associated with obesity, preventively or curatively, by modulating the expression of the protein SPARC or of its activity. It also relates to a method of diagnosing obesity or of one of the disorders associated with obesity by monitoring the rate of expression of the protein SPARC or of its activity. It relates to a composition comprising at least one agent modulating the expression of the SPARC protein or its activity. It also relates to the use of any agent modulating the expression of the protein SPARC or its activity for the preparation of a pharmaceutical composition intended to treat, preventively or curatively, obesity or one of the disorders associated with 'obesity. |
| priorityDate |
2000-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |